New drug duo tested for Tough-to-Treat blood cancer
NCT ID NCT06160843
Summary
This study is testing whether a combination of two existing drugs, pembrolizumab and olaparib, can help control a type of blood cancer called peripheral T-cell lymphoma (PTCL) in adults for whom prior treatments have stopped working. The goal is to see if this drug pair can shrink tumors and extend life. The trial will enroll about 24 participants to closely monitor how well the treatment works and its side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED PERIPHERAL T-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Cancer Centre, Singapore
RECRUITINGSingapore, 168583, Singapore
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.